U.S Futures jump - Watch MRNA, PNC, SPG, TCO, JD, TLRY

,

The S&P 500 Futures are jumping after they returned to positive territory on Friday

Trading floor 2

The S&P 500 Futures are jumping after they returned to positive territory on Friday.

Later today, the New York Federal Reserve will publish November Empire Manufacturing Index (13.8 expected).

European indices have accelerated on the upside after Moderna announced its Covid-19 vaccine met a 94.5% efficacity during its Phase-3 study.

Asian indices ended on a strong advance. Earlier today, government data showed that China's industrial production grew 6.9% on year in October (+6.7% expected). Japan's 3Q annualized GDP rose 21.4% on quarter (+18.9% expected).

WTI Crude Oil is rebounding. The total number of rotary rigs in the U.S. rose to 312 as of November 13 from 300 in the prior week, and rigs in Canada increased to 89 from 86, according to Baker Hughes.

U.S indices closed up on Friday, lifted by Energy (+3.81%), Automobiles & Components (+3.57%) and Consumer Durables & Apparel (+2.36%) sectors.

Approximately 82% of stocks in the S&P 500 Index were trading above their 200-day moving average and 80% were trading above their 20-day moving average. The VIX Index dropped 2.22pts (-8.76%) to 23.13, while Gold gained $11.13 (+0.59%) to $1887.95, and WTI Crude Oil fell $1.01 (-2.46%) to $40.11 at the close.

On the US economic data front, the Producer Price Index Final Demand rose 0.3% on month in October (+0.2% expected), compared to +0.4% in September. Finally, the University of Michigan's Consumer Sentiment Index unexpectedly fell to 77.0 on month in the November preliminary reading (82.0 expected), from 81.8 in the October final reading.

Gold rose 3.42 dollars (+0.18%) to 1892.63 on easing U.S dollar as U.S coronavirus cases continue to climb.

The dollar index fell 0.09pt to 92.668

EUR/USD rose 6pips to 1.184 while GBP/USD gained 13pips to 1.3202 on hopes for compromize regarding Brexit talks.


U.S. Equity Snapshot


Moderna (MRNA), the biotech, jumps premarket after announcing "that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%." 


Source: TradingView, GAIN Capital

PNC Financial Services Group (PNC), a bank holding company, has agreed to acquire Spanish bank BBVA's U.S. business BBVA USA Bancshares for a purchase price of 11.6 billion dollars.

Simon Property Group (SPG), a commercial real estate company, agreed to pay 43.00 dollars per share to acquire Taubman Centers (TCO), down from 52.20 dollars per share originally.

JD.com (JD), the chinese e-commerce company, reporting better than expected quarterly sales up 29% to 26.5 billion dollars.

Tilray (TLRY), the pharmaceutical company, was downgraded to "underperform" from "hold" at Jefferies.

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.